NEWS

March 4, 2010
Acute Lymphoblastic Leukemia in Adolescents and Young Adults: Strategies for Improved Patient Care
A Complimentary Continuing Education Virtual Lecture for Healthcare Professionals

Currently, no definitive standard of care exists for adolescent and young adults (AYA) with acute lymphoblastic leukemia (ALL). Recent research suggests that AYAs treated with pediatric treatment protocols have better outcomes than those treated with adult treatment protocols. It is important that healthcare professionals working with this unique patient population understand and apply evidence-based treatment strategies for ALL in order to maximize patient outcomes.

To view the full press release, please click here.

March 1, 2010
Challenges in Hereditary Angioedema: Expert Viewpoint
Complimentary Continuing Medical Education ReachMD^® Audio Activity for Physicians

There are many obstacles to diagnosing and effectively treating hereditary angioedema (HAE). Symptoms of HAE are often indistinguishable from other conditions and accurate diagnosis requires both detailed patient and family history, as well as a combination of laboratory tests. Symptom management has been the standard of care for many years for acute HAE attacks, however several new therapies have recently been approved by the FDA for HAE. In order to overcome the many challenges in managing the care of patients with HAE, healthcare professionals must be aware of the most current information available regarding HAE diagnosis and treatment strategies.

To view the full press release, please click here.

March 1, 2010
Castrate-Metastatic Prostate Cancer: Therapeutic Considerations for Advanced Disease
A Complimentary Continuing Education Live Webcast for Healthcare Professionals

Castrate-refractory prostate cancer (CRPC), which is characterized by tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Standardized guidelines for treatment of CRPC are lacking and healthcare professionals must consider several factors, including serum markers, patient age and pre-existing comorbidities when choosing between second-line hormonal therapy and chemotherapy for treatment of CRPC. It is critical for healthcare professionals involved in the care of patients with CRPC to understand and utilize the current optimal methods for defining, assessing and treating this condition.

To view the full press release, please click here.

February 25, 2010
Hereditary Angioedema: Viewpoints From the Experts
A Complimentary Continuing Education Virtual Lecture for Healthcare Professionals

Hereditary angioedema (HAE) can be difficult to accurately diagnose and equally difficult to effectively treat. To overcome the many obstacles to managing the care of patients with HAE, healthcare professionals must be aware of the most up-to-date clinical data regarding HAE diagnosis and treatment.

To view the full press release, please click here.

February 1, 2010
Select Topics in ALL: Molecular Characterization, Approaches to CNS Disease, and Post-Remission Transplantation
A Complimentary Continuing Education Virtual Lecture for Healthcare Professionals

Treating acute lymphocytic leukemia (ALL) can bring many challenges, particularly in the adult population. To optimally manage this disease in adult patients, healthcare professionals must understand and identify characteristics of high-risk disease, utilize best strategies for preventing central nervous system relapse, and recognize the important role of post-remission hematopoietic stem cell transplantation in ALL therapy.

To view the full press release, please click here.

January 6, 2010
A Closer Look at Hereditary Angioedema: Expert Perspectives on Optimal Management
A Complimentary Continuing Medical Education Virtual Lecture or Podcast for Physicians

Hereditary angioedema (HAE) is a disease affecting between 4000 and 10,000 people in the United States each year, causing recurrent attacks of intense localized edema. HAE can be both difficult to diagnose and difficult to treat. Symptoms of HAE can resemble other more common conditions, such as allergic reactions. In addition, the available treatments for long-term prophylaxis are associated with significant side effects. To overcome some of the obstacles in diagnosis and treatment, physicians need to be aware of the most up-to-date clinical data regarding HAE.

To view the full press release, please click here.

December 15, 2009
Management of Acute Hereditary Angioedema: Best Strategies for
Emergency Care
A Complimentary Continuing Medical Education Monograph for Physicians

Hereditary angioedema (HAE) is an autosomal dominant disease causing acute attacks of intense edema. These attacks can result in life-threatening complications, including asphyxiation. Management of HAE in the emergency setting can be challenging, therefore it is particularly important for physicians to understand and utilize best practices for recognition and treatment of this complex condition.

To view the full press release, please click here.

October 22, 2009
Hereditary Angioedema (HAE) National Surveillance Project

Hereditary angioedema (HAE) is an autosomal dominant disease estimated to afflict between 1 in 10,000 to 1 in 50,000 people in the United States. Patients with HAE suffer from recurrent attacks of intense localized edema involving the skin, airway, extremities, and visceral organs. Management of HAE may involve short-term treatment and long-term prophylaxis. There are currently several new treatments under investigation for both prophylaxis and acute attacks of HAE.

To view the full press release, please click here.

October 15, 2009
Invasive Fungal Infections in HSCT Recipients: Improving Outcomes Through Prevention and Treatment
A Complimentary Continuing Education Monograph for Healthcare Professionals

Hematopoietic stem cell transplantation (HSCT) and associated immunosuppression is linked to an increased risk of invasive fungal infections (IFIs). IFIs are a significant cause of morbidity and mortality in HSCT recipients. Recent changes in the epidemiology of IFIs have led to an increased frequency of some mold-related and drug-resistant infections, both of which are linked to poor outcomes in patients. It is critical for healthcare professionals who work with HSCT recipients to be aware of novel strategies to prevent and treat IFIs, as these are likely to contribute to improved outcomes in this patient population.

To view the full press release, please click here.

October 8, 2009
Preventing Fungal Infections in HSCT Recipients: Insights from Clinical Cases
A Complimentary Continuing Education Video Virtual Lecture for Healthcare Professionals

Systemic fungal infections are a serious complication of hematopoietic stem cell transplantation (HSCT) and are associated with significant mortality in HSCT recipients. It is critical for healthcare professionals to be aware of the risk factors for fungal infections in HSCT patients and apply optimal strategies for prevention and treatment in this population.

To view the full press release, please click here.

September 10, 2009
New Directions in Angioedema: A Focus on Supportive Care and Treatment Options
A Complimentary Continuing Education Newsletter Series for Healthcare Professionals

Angioedema is characterized by episodes of intense localized edema involving the skin, visceral organs, and airway, causing discomfort and even death as a result of airway obstruction. There are a number of therapies available for the prevention and treatment of angioedema, and new therapies are being studied to further minimize the effect of acute attacks on this patient population.

To view the full press release, please click here.

August 13, 2009
Clostridium difficile Infection: Tracking a Virulent Pathogen
A Complimentary Continuing Education Virtual Lecture for Healthcare Professionals

The rates and severity of Clostridium difficile infection (CDI) may be impacted by several factors, including antimicrobial use, other drug-prescribing factors, infection control practices, and the presence of a new strain of C. difficile that is more resistant to fluoroquinolones and associated with higher rates of morbidity and mortality. It is crucial for healthcare professionals to be aware of these factors and apply evidence-based practices for the prevention, diagnosis, and treatment of CDI.

To view the full press release, please click here.

August 4, 2009
Adult Glioblastoma: Optimal Approaches to a Challenging Diagnosis
A Complimentary Continuing Education Monograph for Healthcare Professionals

Treatment of glioblastoma (GBM), the most common type of glioma, presents many challenges. More than 50% of patients die of disease progression within 18 months of diagnosis. Current treatment includes the use of temozolomide-based chemotherapy, both concurrently with and after completion of radiotherapy. As healthcare professionals gain a better understanding of the molecular biology of GBM and utilize targeted therapies more frequently, there is hope for improving patient outcomes.

To view the full press release, please click here.

July 9, 2009
Changing Paradigms in Hereditary Angioedema: A Focus on Timely Diagnosis and New Therapies
A Complimentary Continuing Medical Education Self-Study Audio Activity for Physicians

Hereditary angioedema (HAE) is an autosomal dominant disease affecting approximately 10,000 people in the United States. HAE causes recurrent attacks of intense localized edema involving the skin, airway, and visceral organs. While chronic therapy with attenuated androgens or plasmin inhibitors has been the mainstay of HAE therapy, many new therapies for prophylaxis and acute treatment are on the horizon. It is important for physicians to understand the signs and symptoms of patients who present with HAE and to be familiar with the conventional and emerging therapies available to treat them.

To view the full press release, please click here.

June 29, 2009
Changing Paradigms in Hereditary Angioedema: Pathophysiology, Diagnosis and Treatment
A Complimentary Continuing Education Monograph for Healthcare Professionals

Hereditary angioedema (HAE) is an autosomal dominant disease affecting between 4000 and 10,000 people in the United States. HAE causes recurrent attacks of intense localized edema involving the skin, airway, and visceral organs. While chronic therapy with attenuated androgens or plasmin inhibitors has been the mainstay of HAE therapy, many new therapies for prophylaxis and acute treatment are on the horizon. It is important for physicians to understand the diagnostic strategies in HAE as well as the conventional and emerging therapeutic options available for HAE prophylaxis and acute attacks.

To view the full press release, please click here.

June 15, 2009
Clostridium difficile Infection: Strategic Approaches for Better Outcomes
A Complimentary Continuing Education Live Lectures for Healthcare Professionals
In recent years, the epidemiology of Clostridium difficile infection (CDI) has been changing. This trend may be the result of antimicrobial use, infection control practices, or other factors. It is critical for healthcare professionals to be aware of the epidemiology of this virulent pathogen and apply evidence-based principles for diagnosis, treatment, and prevention.

To view the full press release, please click here.

June 10, 2009
New Directions in Angioedema: A Focus on Etiologies and Clinical Approach
A Complimentary Continuing Education Newsletter Series for Healthcare Professionals
Angioedema is a clinical syndrome characterized by localized, subcutaneous and/or submucosal swelling. Diagnosing the underlying cause of angioedema can be challenging, as there are multiple etiologies of this condition, all of which produce nearly identical symptoms. It is critical for healthcare professionals to understand the various causes of angioedema, as this is the first step toward accurate diagnosis and management of this complex condition.

To view the full press release, please click here.

June 1, 2009
Adult Glioblastoma: Best Approaches to a Challenging Diagnosis
A Complimentary Continuing Education Lectures for Healthcare Professionals
Adult glioblastoma is a challenging diagnosis that carries a poor prognosis and appears to be associated with genetic alterations of several critical signaling and tumor suppressor pathways. While current treatment options are not curative, there is hope for improving outcomes for patients. In order to do this, healthcare professionals must have an understanding of glioblastoma chromosomal risk factors, new radiation therapy techniques, and strategies to overcome obstacles related to blood-brain barrier penetration.

To view the full press release, please click here.

April 28, 2009
Expert Insights in Acute Lymphoblastic Leukemia: Current Challenges and Future Directions
A Complimentary Continuing Medical Education Online Activity and Podcast for Physicians
Acute lymphoblastic leukemia (ALL) is a complex heterogeneous disease which, despite significant advances in the treatment of pediatric patients, is often fatal in adults. It is critical for physicians who treat adult patients with ALL to maintain an up-to-date understanding of the multitude of factors affecting management options for this challenging disease.

To view the full press release, please click here.

April 22, 2009
Expert Insights in Acute Lymphoblastic Leukemia: Current Challenges and Future Directions
A Complimentary Continuing Education Online Activity and Podcast for Nurses and Pharmacists
Acute lymphoblastic leukemia (ALL) is a complex heterogeneous disease which, despite significant advances in the treatment of pediatric patients, is often fatal in adults. It is critical for healthcare professionals who treat adult patients with ALL to maintain an up-to-date understanding of the multitude of factors affecting management options for this challenging disease.

To view the full press release, please click here.

March 30, 2009
Clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen
A Complimentary Continuing Education Virtual Lecture for Healthcare Professionals
The epidemiology of Clostridium difficile infection (CDI) is changing rapidly and has been marked by a significant increase in incidence and severity. Management of CDI can be challenging and guidelines for treatment and prevention are being updated. In order to effectively implement key strategies for reducing the incidence and severity of this virulent pathogen, it is crucial for primary care physicians to have current education on CDI.

To view the full press release, please click here.

March 27, 2009
New Directions in Angioedema: A Focus on Pathogenesis and Classification
A Complimentary Continuing Education Newsletter for Healthcare Professionals
Evaluation and management of patients with urticaria (hives) and angioedema can be challenging, as both disorders can be caused by a number of immunologic and nonimmunologic mechanisms. Accurate diagnosis is further hindered by the seemingly identical presentation of angioedema subtypes. It is important that healthcare professionals who treat angioedema and urticaria understand the pathophysiology of each angioedema subgroup in order to properly identify and treat acute angioedema episodes.

To view the full press release, please click here.

February 27, 2009
CMV Infection in Solid Organ Transplantation: Clinical Clues and Prevention Strategies
A Complimentary Continuing Medical Education Newsletter for Healthcare Professionals
Cytomegalovirus (CMV) infection is an important cause of morbidity and mortality and is the most common viral opportunistic infection in recipients of solid organ transplant (SOT). Currently, no consensus exists regarding the most appropriate method for preventing CMV, and toxicities and threat of drug resistance occasionally limit the utility of existing antiviral agents. Alternative agents are being investigated, but more research is needed before these are approved for use in SOT recipients. It is important for healthcare professionals to be aware of the current and emerging treatment and prevention strategies for CMV disease in SOT recipients.

To view the full press release, please click here.

February 26, 2009
Interview with GI Experts: Discussions in Clostridium difficile
A Complimentary Continuing Medical Education Virtual Lecture and Podcast
The epidemiology of Clostridium difficile infection (CDI) is changing and has been marked by increasing rates and more severe and complicated disease. Furthermore, the epidemic strain continues to be reported in a growing number of states across the United States, and worldwide.

To view the full press release, please click here.

January 26, 2009
Clostridium difficile Infection: Best Strategies for Care of Older Adults
A Complimentary Continuing Education Monograph for Registered Nurses and Nurse Practitioners
Over the past several years, the incidence and mortality rates of Clostridium difficile infection (CDI) have increased dramatically. CDI is a serious condition, particularly in older adults. Not only are older adults at increased risk for developing CDI, they also have a higher CDI-associated mortality. It is imperative that healthcare professionals be aware of the risk factors, diagnostic considerations, and treatment strategies for CDI in this patient population.

To view the full press release, please click here.

January 20, 2009
Clostridium difficile Infection: Current Challenges and Controversies
A Complimentary Continuing Education Virtual Lecture and Podcast for Healthcare Professionals
Current education about Clostridium difficile infection (CDI) is critical for several reasons. The epidemiology of CDI is changing and has been marked by increasing rates and more severe disease. In addition, the epidemic strain continues to be reported in an expanding list of states across the United States and worldwide.

To view the full press release, please click here.

January 15, 2009
Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management
A Complimentary Continuing Education Virtual Lecture for Healthcare Professionals
Clostridium difficile infection (CDI) is increasingly being seen in older adults, especially among residents of long-term care facilities (LTCFs). This is further complicated by the emergence of a virulent strain of C. difficile associated with high rates of morbidity and mortality.

To view the full press release, please click here.

January 5, 2009
Clostridium difficile Infection: Tools for Treatment and Prevention
A Complimentary Continuing Education Virtual Lecture for Healthcare Professionals
Clostridium difficile infection (CDI) has become an increasingly frequent and severe health problem. The emergence of an epidemic strain of C. difficile has been reported in a growing number of states across the United States and worldwide.

To view the full press release, please click here.

December 20, 2008
Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: An Expert Interview with Dr. Erik R. Dubberke on Practice Recommendations from SHEA/IDSA
A Complimentary Continuing Education Audio Activity for Healthcare Professionals
Clostridium difficile infection (CDI) is a serious gastrointestinal condition which is becoming an increasing burden to the US healthcare system. Research suggests that many facilities do not adhere to optimal infection control practices or surveillance of CDI. Failure to accurately identify and manage outbreaks of CDI can lead to more widespread infection, associated costs and mortality.

To view the full press release, please click here.

December 16, 2008
Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients
A Complimentary Continuing Medical Education Newsletter Series for Physicians
Management of Clostridium difficile infection (CDI) in geriatric and pediatric populations can be challenging and complicated. Because of the observed increase in CDI incidence in many age groups, healthcare professionals need to be especially attuned to the individual needs of these patient populations.

To view the full press release, please click here.

December 15, 2008
CMV Infection in Transplant Recipients: Clinical Cases and Expert Opinion
A Complimentary Continuing Education Virtual Lecture and Podcast for Healthcare Professionals
Cytomegalovirus (CMV) infection is a serious condition and an important cause of morbidity and mortality in recipients of hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT). Controversy exists regarding the best method for CMV prevention. It is important for healthcare professionals working with transplant recipients to be aware of the advantages and limitations of the current strategies available for managing CMV infection and disease in this population.

To view the full press release, please click here.

October 16, 2008
Clostridium difficile Infection: Best Practices for Prevention and Treatment in Long-Term Care
A Complimentary Continuing Education Virtual Lecture for Nurses
Residents of long-term care facilities (LTCFs) are at increased risk of developing Clostridium difficile infection (CDI). Although CDI can be effectively managed with proper treatment and use of strategies that prevent transmission of spores, research suggests that CDI appears to be increasing rapidly in the United States and is disproportionately affecting older persons. In addition, 37 US states and Washington, DC, have reported outbreaks of a novel, hypervirulent strain of C. difficile that poses additional risks to LTCF residents.

To view the full press release, please click here.

October 15, 2008
Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management
A Complimentary Continuing Education Teleconference for Healthcare Professionals
Clostridium difficile infection (CDI) is increasingly being seen in older adults, especially among residents of long-term care facilities (LTCFs). This is further complicated by the emergence of a new resistant strain of C. difficile associated with high rates of morbidity and mortality.

To view the full press release, please click here.

October 1, 2008
Focus on Clostridium difficile: Surveillance and Infection Control Strategies Newsletter
A Complimentary Continuing Education Newsletter for Healthcare Professionals
Clostridium difficile infection (CDI) is a serious gastrointestinal condition that is becoming an increasing burden to the US healthcare system. Rates of CDI in US hospitals have tripled in recent years, and outbreaks of a new, more virulent strain of C. difficile have been identified in 37 US states and Washington, DC. Failure to accurately identify and manage outbreaks of CDI can lead to more widespread infection, associated costs, and mortality; however, recent research has shown that many facilities do not adhere to optimal infection control practices. It is critical that healthcare professionals be aware of the most up-to-date methods of CDI surveillance, prevention, and treatment in order to reduce incidence, severity, and mortality associated with this serious condition.

To view the full press release, please click here.

September 29, 2008
Current Concepts in Clostridium difficile Infection: A Focus on Severe Disease
A Complimentary Continuing Education Newsletter Series for Physicians
Severe Clostridium difficile infection (CDI) is a serious, potentially life-threatening infection that appears to be increasing in incidence across the United States. Severe CDI is frequently accompanied by serious conditions such as hypotension, ileus, toxic megacolon, and perforation. While treatment with vancomycin can be effective, severe CDI often requires total colectomy. It is crucial that healthcare providers who treat patients with CDI be aware of the most effective treatment strategies for this dangerous disease.

To view the full press release, please click here.

September 26, 2008
Clostridium difficile Infection: Tools for Treatment and Prevention
Complimentary Continuing Education Teleconferences for Healthcare Professionals
Clostridium difficile infection (CDI) has become an increasingly frequent and severe health problem. The emergence of an epidemic strain of C. difficile has been reported in an expanding list of states across the United States and worldwide.

To view the full press release, please click here.

September 23, 2008
CMV Disease in Solid Organ Transplant Recipients: A Proactive Approach to Prevention
A Complimentary Continuing Education Monograph for Healthcare Professionals
Cytomegalovirus (CMV) infection is the most common opportunistic viral infection encountered following solid organ transplant (SOT) and a significant cause of morbidity and mortality in recipients of SOT. Prevention of CMV is complicated by several factors, including a lack of consensus regarding the most appropriate preventive methods and the limitations of existing antiviral agents because of toxicity profiles and drug resistance. For these reasons, it is crucial that healthcare professionals working with this population understand strategies for prevention and treatment of CMV infection after SOT.

To view the full press release, please click here.

September 23, 2008
Promising Directions in Hematologic Malignancies: A Guide to Novel Treatments for AML, CLL, and NHL
A Complimentary Continuing Medical Education Monograph for Physicians
Acute myelogenous leukemia (AML) and chronic lymphocytic leukemia (CLL) are the two most common types of leukemia diagnosed in adults nationwide, and non-Hodgkin lymphoma (NHL) is the most common hematologic cancer nationwide. Treatment for these diseases is complex and often associated with significant toxicity. Many promising new therapies are currently being investigated and researchers are optimistic that these therapies will have an impact on overall survival and quality of life in patients.

To view the full press release, please click here.

September 5, 2008
Clostridium difficile: Changing Diagnosis, Epidemiology, and Treatment
A Complimentary Continuing Education Virtual Lecture
In recent years, the rates and severity of Clostridium difficile infection have been increasing. This trend may be the result of changing epidemiology arising from changes in antimicrobial use, other drug-prescribing practices, or infection control practices. The increasing rates may also be the result of a new resistant strain of C. difficile, which is associated with higher rates of morbidity and mortality.

To view the full press release, please click here.

August 14, 2008
Promising Directions in Hematologic Malignancies: A Nurse's Guide to Novel Treatments for AML, CLL, and NHL
A Complimentary Continuing Education Monograph
Chronic lymphocytic leukemia (CLL) and acute myelogenous leukemia (AML) are the two most common types of leukemia diagnosed in adults nationwide, and non-Hodgkin lymphoma (NHL) is the most common hematologic cancer nationwide. Treatment for these diseases is complex and is often associated with significant toxicity. Many promising new therapies are currently being investigated and researchers are optimistic that these therapies will have an impact on improving quality of life and overall survival in patients.

To view the full press release, please click here.

August 14, 2008
CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance
A Complimentary Continuing Education Activity
Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in recipients of hematopoietic stem cell transplantation. The clinical manifestations of CMV disease are serious and range from gastrointestinal disease to life-threatening pneumonia, myelosuppression, retinitis, and encephalitis.

To view the full press release, please click here.

June 30, 2008
Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease
A Complimentary Continuing Education Newsletter Series for Healthcare Professionals
Clostridium difficile infection (CDI) is a serious condition that causes disease with a wide spectrum of severity, ranging from mild diarrhea to pseudomembraneous colitis and death. Recurrent CDI can occur in up to 20% of patients who develop an initial case of CDI. These patients are at increased risk of additional recurrences, as well as more complicated disease, including toxic megacolon, colon perforation, and systemic inflammatory response syndrome with organ failure leading to colectomy or death.

To view the full press release, please click here.

May 1, 2008
Clostridium difficile Infection: Managing Severe Disease in an Era of Change
A Complimentary Continuing Education Lecture Series for Healthcare Professionals
In recent years, the rates and severity of Clostridium difficile infection have been increasing. This trend may be the result of changes in the epidemiology of C. difficile, which may arise from changes in antimicrobial use, other drug prescribing practices, or infection control practices. The increasing rates of C. difficile infection may also be the result of a new strain of C. difficile, one that appears to produce greater quantities of toxins A and B, is more resistant to fluoroquinolones, and is associated with higher rates of morbidity and mortality. In response to the changing epidemiology, guidelines for management are being updated for the first time since 1995 by The Society for Healthcare Epidemiology of America (SHEA) in collaboration with the Infectious Diseases Society of America (IDSA). Healthcare professionals should be aware of the changing epidemiology of this increasingly virulent pathogen and apply evidence-based principles for the diagnoiss and treatment of C. difficile infection.

To view the full press release, please click here.

February 28, 2008
Adult Glioblastoma: Strategies, Challenges, and Opportunities
A Complimentary Continuing Education Lecture Series for
Healthcare Professionals
Glioblastomas are the most common and most malignant type of glioma. Healthcare professionals face many challenges in the treatment of glioblastoma as therapy remains largely palliative, and mean length of survival in patients is less than one year.

To view the full press release, please click here.

January 28, 2008
Interactive Teleconference on Inflammatory Bowel Disease for Patients, Caregivers, and Healthcare Professionals
Educational Teleconference on Medical Therapies to Feature Mayo Clinic Physician
Crohn’s disease and ulcerative colitis patients, caregivers, and healthcare professionals can now register for “Inflammatory Bowel Disease: Why Should I Take My Medications?” This free, live, interactive teleconference through the Crohn’s & Colitis Foundation of America will take place on Thursday, March 6, from 1:00 pm to 2:15 pm EST and will address effective treatment planning for patients with Crohn’s and colitis. Collectively known as inflammatory bowel disease (IBD), these painful and unpredictable digestive diseases debilitate 1.4 million Americans. The teleconference will feature Mayo Clinic College of Medicine physician, Sunanda V. Kane, MD, MSPH, Associate Professor of Medicine.

To view the full press release, please click here.

October 1, 2007
National Experts Team Up to Help Hospitals Prevent and Control
C. difficile Outbreaks
Robert Michael Educational Institute LLC Introduces New Educational
Resource at IDSA Annual Meeting
Robert Michael Educational Institute LLC will introduce a new continuing education resource as part of their exhibit booth at the 45th Annual Meeting of the Infectious Diseases Society of America (IDSA), October 4-7, in San Diego, California. Project CDAD: Outbreak Prevention and Control is designed to assist healthcare providers in preventing and controlling Clostridium difficile-Associated Disease (CDAD) in their hospitals.

To view the full press release, please click here.

March 5, 2007
National Colorectal Cancer Awareness Month
Free Online Education for Nurses, Patients, and Caregivers
Entitled Update on Colorectal Cancer: Knowledge Is Prevention
On March 1, 2007, the Crohn’s & Colitis Foundation of America presented “Update on Colorectal Cancer: Knowledge Is Prevention,” a FREE live educational teleconference for patients, caregivers, and healthcare professionals. If you missed this important program that had 1,500 callers from all over the world, you can now take advantage of this educational lecture, available at www.RMEI.com/ccfavl.

To view the full press release, please click here.

January 29, 2007
Update on Colorectal Cancer: Knowledge Is Prevention
A Complimentary Live Educational Teleconference for Patients, Caregivers,
and Healthcare Professionals
March is Colorectal Cancer Awareness Month. Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Although patients who have ulcerative colitis or Crohn’s disease have the highest risk of developing colorectal cancer, very little guidance has been available on how to identify, monitor, and treat these patients—until now.

To view the full press release, please click here.

January 29, 2007
New Interactive Website Features Data from Clostridium difficile-
Associated Disease (CDAD) Surveillance Project
Clostridium difficile-associated disease (CDAD) has re-emerged as a significant cause of morbidity and mortality in the United States and abroad. To gain a better understanding of the changing epidemiology and clinical impact of CDAD, healthcare professionals in the United States and abroad have been voluntarily providing data to the Clostridium difficile-Associated Disease Surveillance Project (CDSP), a web-based international project. The method of data collection in this surveillance project enables healthcare professionals to customize the data based on geographic location, institution type, and bed size. These CDSP data are being made available today at www.RMEI.com/vrp080.

To view the full press release, please click here.

January 12, 2007
Clostridium difficile-Associated Disease in the Long-Term Care Setting
A Complimentary Online Continuing Education Activity
Healthcare professionals who work in long-term care facilities (LTCFs) should be aware of the emergence of a new strain of Clostridium difficile that produces greater quantities of toxins A and B, is more resistant to fluoroquinolones, and is associated with higher rates of morbidity and mortality.

To view the full press release, please click here.

January 11, 2007
Robert Michael Educational Institute LLC Announces Personnel Changes:
Sherri Kramer, MD, is Hired as Director, Medical Affairs
Jessica G. Parenti is Promoted to Vice President
Robert Michael Educational Institute LLC (RMEI) is pleased to announce two personnel changes, effective immediately. Sherri Kramer, MD, has joined the company as a full-time Director, Medical Affairs. In addition, Jessica G. Parenti has been promoted to Vice President from her previous position as Senior Director, Professional Programs.

To view the full press release, please click here.